Metraipolis › archive › dc_70c2fc305e66
Beyond Molecular Characterization: The Impact of Age-Adjusted Charlson Comorbidity Index in Glioblastoma Patients Treated with Radio or Radio-Chemotherapy — Europe PMC PMID:41226912
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41226912
- DOI
- 10.3390/jcm14217515
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T02:58:48.219Z
- SHA-256 of the archived text
0a7fd5e1b62740f982a08049c8dd7ed245e649fe17196d294b02dad3eaa6b92b- Stable URL of this page
https://metraipolis.com/documento/dc_70c2fc305e66
How to cite
Beyond Molecular Characterization: The Impact of Age-Adjusted Charlson Comorbidity Index in Glioblastoma Patients Treated with Radio or Radio-Chemotherapy — Europe PMC PMID:41226912 — Europe PMC (en), https://europepmc.org/article/MED/41226912 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_70c2fc305e66 (Metraipolis archive dc_70c2fc305e66, sha256 0a7fd5e1b62740f982a08049c8dd7ed245e649fe17196d294b02dad3eaa6b92b)
BibTeX
@misc{dc70c2fc305e66,
title = {Beyond Molecular Characterization: The Impact of Age-Adjusted Charlson Comorbidity Index in Glioblastoma Patients Treated with Radio or Radio-Chemotherapy — Europe PMC PMID:41226912},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41226912},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_70c2fc305e66; sha256 0a7fd5e1b62740f982a08049c8dd7ed245e649fe17196d294b02dad3eaa6b92b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41226912. Agents can read the archived copy with the MCP tool read_document.